NCT04952454

Brief Summary

135 eyes of 135 patients treated between 2005 and 2017 will be included in this study. The diagnosis of functional epiphora was made based on a patent lacrimal system with a delay in the fluorescein dye disappearance test (FDDT) or dacryoscintigraphy (DSG) without any ocular surface or eyelid abnormalities. The absence of epiphora and normalization of FDDT postoperatively was defined as success. The study's hypothesis is that external DCR with a suitable technique will have better results compared to endonasal and transcanalicular DCR

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
135

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 1, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 7, 2021

Completed
Last Updated

July 7, 2021

Status Verified

July 1, 2021

Enrollment Period

1 month

First QC Date

July 1, 2021

Last Update Submit

July 6, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients who report resolution of theri tearing and normalization of fluorescein dye disappearance test.

    Last follow-up time, approximately 6 months

Secondary Outcomes (1)

  • Number of patients who have continuing epiphora after the surgery with an anatomically blocked tear duct.

    Last follow-up time, approximately 6 months

Study Arms (3)

External DCR

ACTIVE COMPARATOR

Patients treated with External DCR for functional epiphora

Procedure: External Dacryocystorhinostomy

Endonasal DCR

ACTIVE COMPARATOR

Patients treated with Endonasal DCR for functional epiphora

Procedure: Endonasal Dacryocystorhinostomy

Transcanalicular DCR

ACTIVE COMPARATOR

Patients treated with Transcanalicular DCR for functional epiphora

Procedure: Transcanalicular Dacryocystorhinostomy

Interventions

The resistance of the lacrimal drainage is lowered by creating a new ostium between the lacrimal sac and nasal cavity via skin incision.

External DCR

The resistance of the lacrimal drainage is lowered by creating a new ostium between the lacrimal sac and nasal cavity via endonasal route.

Endonasal DCR

The resistance of the lacrimal drainage is lowered by creating a new ostium between the lacrimal sac and nasal cavity via transcanalicular route.

Transcanalicular DCR

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patent lacrimal irrigation and delay in the lacrimal transit time demonstrated by fluorescein dye disappearance test (FDDT) or a dacryoscintigraphy (DSG)

You may not qualify if:

  • Dry eye (tear break up time less than 10 seconds), ocular surface disorders, eyelid malposition or laxity, orbicularis weakness, partial block or stenosis of the lacrimal drainage, history of previous nasal, lacrimal, or ophthalmic surgeries, and a postoperative follow-up time less than six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

McMaster University

Hamilton, Ontario, L8S 4L8, Canada

Location

Beyoglu Eye Research Hospital

Istanbul, 34421, Turkey (Türkiye)

Location

Study Officials

  • Can Ozturker, MD

    Istanbul University, Istanbul Facukty Of Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asist. Prof.

Study Record Dates

First Submitted

July 1, 2021

First Posted

July 7, 2021

Study Start

May 1, 2021

Primary Completion

June 1, 2021

Study Completion

June 1, 2021

Last Updated

July 7, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations